Abstract
The aim was to determine the course, outcome, and determinants of mortality in patients with systemic lupus erythematosus (SLE) in intensive care unit (ICU). SLE patients admitted to ICU from 2004 to 2015 were recruited retrospectively. Demographic data, disease characteristics, causes of admission, baseline SLE disease activity index-2K (SLEDAI-2K) and Acute Physiologic and Chronic Health Evaluation II (APACHE) score, the outcome, and the causes of death were recorded. Predictors of mortality were compared between alive and dead patients by Cox regression analysis. Ninety-four patients with SLE were enrolled. Mean age at the time of ICU admission was 29.6 years. Average scores of SLEDAI and APACHE II were 11.3 and 19.8, respectively. The most common causes of ICU admission were pneumonia, diffuse alveolar hemorrhage (DAH), and seizure. Forty-seven patients (50%) died in ICU. The principal causes of death were septic shock (25.5%), multi-organ failure (12.5%), DAH (10.6%), and pneumonia (10.6%). After multivariate analysis, high APACHE II, septic shock, and duration of mechanical ventilation were indicators of survival outcome. Mean (95% CI) survival days in ICU in patients with and without respiratory failure were 14.6 (10.4–18.9) and 28.7 (17.9–39.5) days, respectively (P = 0.001). This figure for those with and without septic shock was 13.5 (4.9–11.1) and 22.3 (9.3–24.7) days, respectively (P = 0.016). High APACHE II, septic shock, and duration of mechanical ventilation were the main predictors of death in patients with SLE in ICU. Multicenter studies are needed to draw a fine picture of SLE behavior in ICU.
Similar content being viewed by others
References
Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12(3):380–395. https://doi.org/10.1016/j.autrev.2012.06.002
Lee JW, Park DJ, Kang JH, Choi SE, Yim YR, Kim JE, Lee KE, Wen L, Kim TJ, Park YW, Sung YK, Lee SS (2016) The rate of and risk factors for frequent hospitalization in systemic lupus erythematosus: results from the Korean lupus network registry. Lupus 25(13):1412–1419. https://doi.org/10.1177/0961203316640916
Gu K, Gladman DD, Su J, Urowitz MB (2017) Hospitalizations in patients with systemic lupus erythematosus in an academic health science center. J Rheumatol 44(8):1173–1178. https://doi.org/10.3899/jrheum.170072
Siripaitoon B, Lertwises S, Uea-Areewongsa P, Khwannimit B (2015) A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality. Lupus 24(1):98–106. https://doi.org/10.1177/0961203314548884
Namendys-Silva SA, Baltazar-Torres JA, Rivero-Sigarroa E, Fonseca-Lazcano JA, Montiel-Lopez L, Dominguez-Cherit G (2009) Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus 18(14):1252–1258. https://doi.org/10.1177/0961203309345720
Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY, Yu CL, Yang PC (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 9(3):R177–R183. https://doi.org/10.1186/cc3481
Bernal-Macias S, Reyes-Beltran B, Molano-Gonzalez N, Augusto Vega D, Bichernall C, Diaz LA, Rojas-Villarraga A, Anaya JM (2015) Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med 2(1):e000122. https://doi.org/10.1136/lupus-2015-000122
Lee J, Dhillon N, Pope J (2013) All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) 52(5):905–909. https://doi.org/10.1093/rheumatology/kes391
Couto Dde O, Feijo CA, Aguiar SM, Meneses FA (2008) Characteristics of patients with systemic lupus erythematosus admitted to the intensive care unit in a brazilian teaching hospital. Rev Bras Ter Intensiva 20(3):249–253
Whitelaw DA, Gopal R, Freeman V (2005) Survival of patients with SLE admitted to an intensive care unit—a retrospective study. Clin Rheumatol 24(3):223–227. https://doi.org/10.1007/s10067-004-1007-3
Alzeer AH, Al-Arfaj A, Basha SJ, Alballa S, Al-Wakeel J, Al-Arfaj H, Al-Sugair S, Al-Mugeiren S, Al-Shamairi M, Bamgboye EA (2004) Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 13(7):537–542
Williams FM, Chinn S, Hughes GR, Leach RM (2002) Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 61(5):414–421
Shen HN, Yang HH, Lu CL (2013) Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: a national population-based study. Lupus 22(6):644–652. https://doi.org/10.1177/0961203313476356
McAlindon T, Giannotta L, Taub N, D’ Cruz D, Hughes G (1993) Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 52(10):720–724
Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS (1998) Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 41(10):1714–1724. https://doi.org/10.1002/1529-0131(199810)41:10<1714::aid-art3>3.0.co;2-u
Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85(3):147–156. https://doi.org/10.1097/01.md.0000224709.70133.f7
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/1529–0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818–829
Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291
Santos-Ocampo AS, Mandell BF, Fessler BJ (2000) Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 118(4):1083–1090
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179–c184. https://doi.org/10.1159/000339789
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864–874
Raj R, Murin S, Matthay RA, Wiedemann HP (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18(4):781–803
Han BK, Bhatia R, Traisak P, Hunter K, Milcarek B, Schorr C, Eid H, Feinstein D, Cronin P, Kolasinski SL (2013) Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit. Lupus 22(7):690–696. https://doi.org/10.1177/0961203313490240
Ansell SM, Bedhesi S, Ruff B, Mahomed AG, Richards G, Mer M, Feldman C (1996) Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 24(6):981–984
Cavallasca JA, Del Rosario MM, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A, Nasswetter GG (2010) Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol 16(8):400–402. https://doi.org/10.1097/RHU.0b013e3181ffe517
Dumas G, Geri G, Montlahuc C, Chemam S, Dangers L, Pichereau C, Brechot N, Duprey M, Mayaux J, Schenck M, Boisrame-Helms J, Thomas G, Baboi L, Mouthon L, Amoura Z, Papo T, Mahr A, Chevret S, Chiche JD, Azoulay E (2015) Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest 148(4):927–935. https://doi.org/10.1378/chest.14-3098
Rees F, Doherty M, Grainge MJ, Lanyon P, Davenport G, Zhang W (2016) Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012. Rheumatology (Oxford) 55(5):854–860. https://doi.org/10.1093/rheumatology/kev424
Feng PH, Lin SM, Yu CT, Yu KH, Huang CD, Tsai YH, Kuo HP (2010) Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit. Am J Med Sci 340(1):64–68. https://doi.org/10.1097/MAJ.0b013e3181e0ef9b
Heijnen T, Wilmer A, Blockmans D, Henckaerts L (2016) Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study. Scand J Rheumatol 45(2):146–150. https://doi.org/10.3109/03009742.2015.1067329
Spicher JE, White DP (1987) Outcome and function following prolonged mechanical ventilation. Arch Intern Med 147(3):421–425
Cox CE, Martinu T, Sathy SJ, Clay AS, Chia J, Gray AL, Olsen MK, Govert JA, Carson SS, Tulsky JA (2009) Expectations and outcomes of prolonged mechanical ventilation. Crit Care Med 37(11):2888–2894; quiz 2904. https://doi.org/10.1097/CCM.0b013e3181ab86ed
Chelluri L, Im KA, Belle SH, Schulz R, Rotondi AJ, Donahoe MP, Sirio CA, Mendelsohn AB, Pinsky MR (2004) Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med 32(1):61–69. https://doi.org/10.1097/01.ccm.0000098029.65347.f9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Fatemi, A., Shamsaee, S., Raeisi, A. et al. Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit. Clin Rheumatol 36, 2471–2477 (2017). https://doi.org/10.1007/s10067-017-3808-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3808-1